Home/Filings/4/0001181431-12-050576
4//SEC Filing

Hasara Garrison J. 4

Accession 0001181431-12-050576

CIK 0001310094other

Filed

Sep 13, 8:00 PM ET

Accepted

Sep 14, 4:45 PM ET

Size

5.7 KB

Accession

0001181431-12-050576

Insider Transaction Report

Form 4
Period: 2012-08-24
Hasara Garrison J.
Acting Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2012-08-24+109,654109,654 total
    Exercise: $0.15From: 2012-08-24Exp: 2017-08-24Common Stock (109,654 underlying)
Footnotes (3)
  • [F1]The options were delivered to and received by employee on September 14, 2012.
  • [F2]The options shall vest as follows: (a) 33,654 vest immediately; (b) 10,857 on September 28, 2012; and (c) 10,857 for each of six successive two-week intervals after September 28, 2012 through and including December 21, 2012.
  • [F3]The options terminate 5 years from the grant date, or 90 days after the employee ceases to be an employee for any reason, other than death, disability or retirement.

Documents

1 file

Issuer

ACCENTIA BIOPHARMACEUTICALS INC

CIK 0001310094

Entity typeother

Related Parties

1
  • filerCIK 0001510349

Filing Metadata

Form type
4
Filed
Sep 13, 8:00 PM ET
Accepted
Sep 14, 4:45 PM ET
Size
5.7 KB